295 results on '"Teishima, J."'
Search Results
2. 169 Impact of Low-Intensity Extracorporeal Shock Wave Therapy on Sexual Function after Non-Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy
3. A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial
4. Clinicopathological characteristics of upper tract urothelial cancer with loss of immunohistochemical expression of mismatch repair proteins
5. Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence
6. Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome: PO-04
7. Transition of ANXA10 expression is a useful diagnostic and prognostic marker in upper tract urothelial carcinoma
8. Recurrence and progression free survival of intermediate risk NMIBC: The impact of conditional evaluation and sub-classification
9. Prediction for early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors
10. Longitudinal analysis of conventional laparoscopic, posterior retroperitoneoscopic, and laparoendoscopic single-site adrenalectomy regarding cosmesis and satisfaction outcomes
11. Longitudinal evaluation of frequency of patients taking part in sexual intercourse and sexual activities after undergoing robot-assisted laparoscopic radical prostatectomy
12. Impact of low-intensity extracorporeal shock wave therapy on sexual function after non-nerve-sparing robot-assisted laparoscopic radical prostatectomy
13. Restration of IGFBP-rP1 in human prostate cancer
14. KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
15. Parallels between immunohistochemical classification of upper and lower tract urothelial carcinoma using markers of urothelial differentiation
16. Improved prognosis for old-aged patients with metastatic renal cell carcinoma after targeted therapy
17. Accurate clinical T3 staging by a computed tomography scoring system is an independent preoperative predictor of survival in patients with urothelial carcinoma of the ureter
18. PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
19. 318 - Longitudinal evaluation of health related quality of life following laparoscopic adrenalectomy: Impact of adrenalectomy on cortisol-producing adenoma
20. Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer
21. Comparisons of surgeons’ and assistants’ fatigue after laparoendoscopic single-site versus conventional laparoscopic adrenalectomy: A single surgeon’s experience
22. Longitudinal evaluation of health related quality of life following laparoscopic adrenalectomy: Impact of adrenalectomy on cortisol-producing adenoma
23. Prognostic impact of immunohistochemical classification of bladder cancer according to luminal (Uroplakin III) and basal (Cytokeratin 5/6) markers
24. PT367 - Accurate clinical T3 staging by a computed tomography scoring system is an independent preoperative predictor of survival in patients with urothelial carcinoma of the ureter
25. 1155 - Improved prognosis for old-aged patients with metastatic renal cell carcinoma after targeted therapy
26. 851 - KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
27. 731 - Parallels between immunohistochemical classification of upper and lower tract urothelial carcinoma using markers of urothelial differentiation
28. 260 - PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
29. 853 Prevalence of hand joint symptoms of androgen deprivation therapy in Japanese prostate cancer patients
30. 1070 Regenerating islet-derived related protein 4 as candidate of a novel biomarker in castration-resistant prostate cancer patients
31. 110 Combination therapy using molecular-targeted drugs inhibiting platelet-derived growth factor receptors in the tumor microenvironment of renal cell carcinoma
32. 493 Longitudinal evaluation of patient-reported cosmesis outcome following laparoscopic adrenalectomy: Laparoendoscopic single-site adrenalectomy vs conventional laparoscopic adrenalectomy
33. 121 TSPAN8 expression in renal cell carcinoma is a poor prognostic factor and a novel therapeutic target
34. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation
35. 111 - Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer
36. 12 - Comparisons of surgeons’ and assistants’ fatigue after laparoendoscopic single-site versus conventional laparoscopic adrenalectomy: A single surgeon’s experience
37. 9 The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in metastatic renal cell carcinoma patients
38. 16 Comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients
39. 47 Regeneration of rat corpus cavernosa tissue after transplantation of CD 133+ cells derived from human bone marrow and placement of biodegradable gel sponge sheet
40. 669 A phase III, multicenter, randomized, controlled study of maximum androgen blockade with vs without zoledronic acid in prostate cancer patients with metastatic bone disease: Results of main secondary endpoints in ZAPCA trial
41. 485 Impact of spatial cognitive ability on the proficiency of urological surgeons in robot-assisted surgery using mimic dV-trainer
42. 387 - Prognostic impact of immunohistochemical classification of bladder cancer according to luminal (Uroplakin III) and basal (Cytokeratin 5/6) markers
43. 208 Regenerating islet-derived family, member 4 enhances cell proliferation, castration-resistance and chemoresistance through acceleration of neuroendocrine differentiation in human prostate cancer cells
44. P143 Usefulness of flomoxef in the prevention of infection complicating transrectal prostate needle biopsy
45. 462 Patient-reported satisfaction and cosmesis outcomes following laparoscopic adrenalectomy: LESS vs conventional laparoscopic surgery
46. 666 Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome
47. 546 Localization of fibroblast growth factor 9 in prostate cancer cells Is associated with postoperative recurrence
48. 984 Prevalence of hand joint symptoms of androgen deprivation therapy in Japanese prostate cancer patients
49. Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence
50. 254 DSC2 IS A NEW IMMUNOHISTOCHEMICAL MARKER INDICATIVE OF SQUAMOUS CELL CARCINOMA COMPONENT IN URINARY BLADDER CANCER AND A VALUABLE PROGNOSTIC FACTOR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.